{"id":6003,"date":"2024-10-04T08:54:06","date_gmt":"2024-10-04T08:54:06","guid":{"rendered":"https:\/\/presspart.com\/invox-pharma-and-ht-presspart-announce-strategic-partnership-to-manufacture-the-device-sub-assembly-for-commercialisation-of-the-softhaler\/"},"modified":"2024-11-07T12:05:26","modified_gmt":"2024-11-07T12:05:26","slug":"invox-pharma-and-ht-presspart-announce-strategic-partnership-to-manufacture-the-device-sub-assembly-for-commercialisation-of-the-softhaler","status":"publish","type":"post","link":"https:\/\/presspart.com\/es\/invox-pharma-and-ht-presspart-announce-strategic-partnership-to-manufacture-the-device-sub-assembly-for-commercialisation-of-the-softhaler\/","title":{"rendered":"invoX Pharma y H&T Presspart anuncian una colaboraci\u00f3n estrat\u00e9gica para fabricar el subconjunto del dispositivo para la comercializaci\u00f3n del Softhaler\u00ae."},"content":{"rendered":"\n
\"\"<\/figure>\n\n\n\n

<\/p>\n\n\n\n

L’Arbo\u00e7, Espa\u00f1a – 4 de octubre de 2024 – invoX Pharma Limited (\u00abinvoX\u00bb), una compa\u00f1\u00eda biofarmac\u00e9utica global impulsada por la investigaci\u00f3n, ha iniciado una nueva colaboraci\u00f3n estrat\u00e9gica con H&T Presspart (una divisi\u00f3n del Grupo Heitkamp & Thumann), un desarrollador y fabricante por contrato l\u00edder de componentes y dispositivos de administraci\u00f3n de f\u00e1rmacos.<\/p>\n\n\n\n

A trav\u00e9s de esta colaboraci\u00f3n, H&T Presspart fabricar\u00e1 el subconjunto del dispositivo para la comercializaci\u00f3n del complejo dispositivo de inhalaci\u00f3n de nebulizaci\u00f3n suave (SMI) de invoX, el Softhaler\u00ae. Como socio designado de invoX para la industrializaci\u00f3n y fabricaci\u00f3n, H&T Presspart moldear\u00e1 los componentes y producir\u00e1 los subconjuntos en una sala blanca espec\u00edfica en sus instalaciones de Tarragona (Espa\u00f1a).<\/p>\n\n\n\n

El Softhaler\u00ae es una plataforma de inhalaci\u00f3n por nebulizaci\u00f3n suave de nueva generaci\u00f3n que utiliza una tecnolog\u00eda diferenciada para administrar al pulm\u00f3n formulaciones de base l\u00edquida sin propelentes. Se trata de un dispositivo puramente mec\u00e1nico que utiliza formulaciones a base de agua y no contiene propelentes. El dispositivo Softhaler\u00ae convierte mec\u00e1nicamente la formulaci\u00f3n l\u00edquida en una niebla ultrafina para administrar la medicaci\u00f3n a los pulmones de forma m\u00e1s eficaz, lo que se traduce en una mejor administraci\u00f3n pulmonar y una menor deposici\u00f3n en la boca o en la parte posterior de la garganta.<\/p>\n\n\n\n

invoX Pharma tiene varios acuerdos en vigor para el desarrollo y la comercializaci\u00f3n de productos gen\u00e9ricos e innovadores de combinaci\u00f3n f\u00e1rmaco-dispositivo utilizando el Softhaler\u00ae.<\/p>\n\n\n\n

\u00abEstamos encantados de trabajar con un experto en el campo de la fabricaci\u00f3n de componentes y el ensamblaje de dispositivos m\u00e9dicos\u00bb, declar\u00f3 Ben Toogood, consejero delegado de invoX. \u00abEsta asociaci\u00f3n nos proporcionar\u00e1 capacidad de fabricaci\u00f3n a escala comercial para nuestro dispositivo, lo que constituye un paso clave en la colaboraci\u00f3n con nuestros socios de desarrollo para llevar el Softhaler al mercado. Estamos centrados en llevar el Softhaler a los pacientes con enfermedades respiratorias, para que puedan beneficiarse de los medicamentos administrados a trav\u00e9s de nuestro dispositivo de pr\u00f3xima generaci\u00f3n.\u00bb<\/p>\n\n\n\n

Christian Kr\u00e4tzig, Presidente de H&T Presspart, coment\u00f3: \u00abEsta asociaci\u00f3n subraya nuestro compromiso estrat\u00e9gico de apoyar a los clientes en la comercializaci\u00f3n de productos combinados f\u00e1rmaco-dispositivo de alta complejidad. Como desarrollador y fabricante l\u00edder de dispositivos de administraci\u00f3n de f\u00e1rmacos y nuestra experiencia en el mercado de la inhalaci\u00f3n, estamos encantados de asociarnos con invoX para llevar la pr\u00f3xima generaci\u00f3n de SMI a pacientes de todo el mundo.\u00bb<\/p>\n\n\n\n

Acerca de invoX Pharma<\/strong><\/p>\n\n\n\n

invoX Pharma es una empresa biofarmac\u00e9utica global impulsada por la investigaci\u00f3n que utiliza plataformas tecnol\u00f3gicas de \u00faltima generaci\u00f3n para descubrir y desarrollar medicamentos innovadores que puedan cambiar la vida de personas de todo el mundo. La compa\u00f1\u00eda aspira a mejorar la vida de las personas mediante la creaci\u00f3n de acceso a medicamentos innovadores que aborden sus necesidades insatisfechas de atenci\u00f3n m\u00e9dica. Constituida en marzo de 2021, invoX se centra principalmente en la oncolog\u00eda y la terap\u00e9utica respiratoria, con actividades de investigaci\u00f3n, desarrollo cl\u00ednico y desarrollo empresarial en el Reino Unido, la UE y los Estados Unidos. Para m\u00e1s informaci\u00f3n sobre invoX Pharma, visite: https:\/\/invoxpharma.com\/<\/p>\n\n\n\n

Acerca de H&T Presspart:<\/strong><\/p>\n\n\n\n

H&T Presspart es un fabricante l\u00edder del mercado de dispositivos y componentes para la administraci\u00f3n de f\u00e1rmacos con m\u00e1s de 50 a\u00f1os de experiencia y goza de una reputaci\u00f3n mundial por su competencia, calidad e innovaci\u00f3n en el mercado farmac\u00e9utico. Como l\u00edder mundial en el mercado de la inhalaci\u00f3n, H&T Presspart ofrece soluciones integradas para apoyar la transici\u00f3n de la industria a propelentes de bajo GWP. En combinaci\u00f3n con una amplia cartera de componentes y soluciones de dispositivos, H&T Presspart ofrece desarrollo de productos y servicios anal\u00edticos para acelerar la comercializaci\u00f3n de los programas de administraci\u00f3n de f\u00e1rmacos de los clientes. Como una de las primeras del sector, H&T Presspart anunci\u00f3 una inversi\u00f3n para establecer una planta de llenado equipada para llenar inhaladores de dosis medidas con propelentes de bajo GWP en 2022. H&T Presspart cuenta con 4 plantas de fabricaci\u00f3n europeas en Alemania, Espa\u00f1a, Suiza y el Reino Unido y tiene representaci\u00f3n comercial en China, India, EE.UU. y Uruguay.<\/p>\n\n\n\n

M\u00e1s informaci\u00f3n: www.presspart.com<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

L’Arbo\u00e7, Espa\u00f1a – 4 de octubre de 2024 – invoX Pharma Limited (\u00abinvoX\u00bb), una compa\u00f1\u00eda biofarmac\u00e9utica global impulsada por la investigaci\u00f3n, ha iniciado una nueva colaboraci\u00f3n estrat\u00e9gica con H&T Presspart (una divisi\u00f3n…<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[27,43],"tags":[],"class_list":["post-6003","post","type-post","status-publish","format-standard","hentry","category-company-news-es","category-products-and-services-es"],"acf":[],"yoast_head":"\ninvoX Pharma and H&T Presspart Announce Strategic Partnership<\/title>\n<meta name=\"description\" content=\"H&T Presspart will manufacture the device sub-assembly for the commercialisation of invoX\u2019s complex soft mist inhalation (SMI) device, the Softhaler\u00ae. As invoX\u2019s designated industrialisation and manufacturing partner, H&T Presspart will mould components and produce sub-assemblies in a dedicated clean room at their site in Tarragona, Spain.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/presspart.com\/es\/invox-pharma-and-ht-presspart-announce-strategic-partnership-to-manufacture-the-device-sub-assembly-for-commercialisation-of-the-softhaler\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"invoX Pharma and H&T Presspart Announce Strategic Partnership\" \/>\n<meta property=\"og:description\" content=\"H&T Presspart will manufacture the device sub-assembly for the commercialisation of invoX\u2019s complex soft mist inhalation (SMI) device, the Softhaler\u00ae. As invoX\u2019s designated industrialisation and manufacturing partner, H&T Presspart will mould components and produce sub-assemblies in a dedicated clean room at their site in Tarragona, Spain.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/presspart.com\/es\/invox-pharma-and-ht-presspart-announce-strategic-partnership-to-manufacture-the-device-sub-assembly-for-commercialisation-of-the-softhaler\/\" \/>\n<meta property=\"og:site_name\" content=\"H&T Presspart\" \/>\n<meta property=\"article:published_time\" content=\"2024-10-04T08:54:06+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-11-07T12:05:26+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/presspart.com\/wp-content\/uploads\/2024\/10\/Website-News-Heads-1024x443.png\" \/>\n<meta name=\"author\" content=\"presspart\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"presspart\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/presspart.com\/es\/invox-pharma-and-ht-presspart-announce-strategic-partnership-to-manufacture-the-device-sub-assembly-for-commercialisation-of-the-softhaler\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/presspart.com\/es\/invox-pharma-and-ht-presspart-announce-strategic-partnership-to-manufacture-the-device-sub-assembly-for-commercialisation-of-the-softhaler\/\"},\"author\":{\"name\":\"presspart\",\"@id\":\"https:\/\/presspart.com\/es\/#\/schema\/person\/ea6faba4b50e03fce829becbe473e66f\"},\"headline\":\"invoX Pharma y H&T Presspart anuncian una colaboraci\u00f3n estrat\u00e9gica para fabricar el subconjunto del dispositivo para la comercializaci\u00f3n del Softhaler\u00ae.\",\"datePublished\":\"2024-10-04T08:54:06+00:00\",\"dateModified\":\"2024-11-07T12:05:26+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/presspart.com\/es\/invox-pharma-and-ht-presspart-announce-strategic-partnership-to-manufacture-the-device-sub-assembly-for-commercialisation-of-the-softhaler\/\"},\"wordCount\":795,\"image\":{\"@id\":\"https:\/\/presspart.com\/es\/invox-pharma-and-ht-presspart-announce-strategic-partnership-to-manufacture-the-device-sub-assembly-for-commercialisation-of-the-softhaler\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/presspart.com\/wp-content\/uploads\/2024\/10\/Website-News-Heads-1024x443.png\",\"articleSection\":[\"Noticias de Empresa\",\"Productos y Servicios\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/presspart.com\/es\/invox-pharma-and-ht-presspart-announce-strategic-partnership-to-manufacture-the-device-sub-assembly-for-commercialisation-of-the-softhaler\/\",\"url\":\"https:\/\/presspart.com\/es\/invox-pharma-and-ht-presspart-announce-strategic-partnership-to-manufacture-the-device-sub-assembly-for-commercialisation-of-the-softhaler\/\",\"name\":\"invoX Pharma and H&T Presspart Announce Strategic Partnership\",\"isPartOf\":{\"@id\":\"https:\/\/presspart.com\/es\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/presspart.com\/es\/invox-pharma-and-ht-presspart-announce-strategic-partnership-to-manufacture-the-device-sub-assembly-for-commercialisation-of-the-softhaler\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/presspart.com\/es\/invox-pharma-and-ht-presspart-announce-strategic-partnership-to-manufacture-the-device-sub-assembly-for-commercialisation-of-the-softhaler\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/presspart.com\/wp-content\/uploads\/2024\/10\/Website-News-Heads-1024x443.png\",\"datePublished\":\"2024-10-04T08:54:06+00:00\",\"dateModified\":\"2024-11-07T12:05:26+00:00\",\"author\":{\"@id\":\"https:\/\/presspart.com\/es\/#\/schema\/person\/ea6faba4b50e03fce829becbe473e66f\"},\"description\":\"H&T Presspart will manufacture the device sub-assembly for the commercialisation of invoX\u2019s complex soft mist inhalation (SMI) device, the Softhaler\u00ae. As invoX\u2019s designated industrialisation and manufacturing partner, H&T Presspart will mould components and produce sub-assemblies in a dedicated clean room at their site in Tarragona, Spain.\",\"breadcrumb\":{\"@id\":\"https:\/\/presspart.com\/es\/invox-pharma-and-ht-presspart-announce-strategic-partnership-to-manufacture-the-device-sub-assembly-for-commercialisation-of-the-softhaler\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/presspart.com\/es\/invox-pharma-and-ht-presspart-announce-strategic-partnership-to-manufacture-the-device-sub-assembly-for-commercialisation-of-the-softhaler\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/presspart.com\/es\/invox-pharma-and-ht-presspart-announce-strategic-partnership-to-manufacture-the-device-sub-assembly-for-commercialisation-of-the-softhaler\/#primaryimage\",\"url\":\"https:\/\/presspart.com\/wp-content\/uploads\/2024\/10\/Website-News-Heads-1024x443.png\",\"contentUrl\":\"https:\/\/presspart.com\/wp-content\/uploads\/2024\/10\/Website-News-Heads-1024x443.png\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/presspart.com\/es\/invox-pharma-and-ht-presspart-announce-strategic-partnership-to-manufacture-the-device-sub-assembly-for-commercialisation-of-the-softhaler\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/presspart.com\/es\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"invoX Pharma y H&T Presspart anuncian una colaboraci\u00f3n estrat\u00e9gica para fabricar el subconjunto del dispositivo para la comercializaci\u00f3n del Softhaler\u00ae.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/presspart.com\/es\/#website\",\"url\":\"https:\/\/presspart.com\/es\/\",\"name\":\"H&T Presspart\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/presspart.com\/es\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/presspart.com\/es\/#\/schema\/person\/ea6faba4b50e03fce829becbe473e66f\",\"name\":\"presspart\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/presspart.com\/es\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/f132ba1b1a5a3d6f3cb6529cef071eedff6082ffed6f37fb7fbbf8dde5dedb6e?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/f132ba1b1a5a3d6f3cb6529cef071eedff6082ffed6f37fb7fbbf8dde5dedb6e?s=96&d=mm&r=g\",\"caption\":\"presspart\"},\"sameAs\":[\"http:\/\/presspart.local\"],\"url\":\"https:\/\/presspart.com\/es\/author\/presspart\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"invoX Pharma and H&T Presspart Announce Strategic Partnership","description":"H&T Presspart will manufacture the device sub-assembly for the commercialisation of invoX\u2019s complex soft mist inhalation (SMI) device, the Softhaler\u00ae. As invoX\u2019s designated industrialisation and manufacturing partner, H&T Presspart will mould components and produce sub-assemblies in a dedicated clean room at their site in Tarragona, Spain.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/presspart.com\/es\/invox-pharma-and-ht-presspart-announce-strategic-partnership-to-manufacture-the-device-sub-assembly-for-commercialisation-of-the-softhaler\/","og_locale":"es_ES","og_type":"article","og_title":"invoX Pharma and H&T Presspart Announce Strategic Partnership","og_description":"H&T Presspart will manufacture the device sub-assembly for the commercialisation of invoX\u2019s complex soft mist inhalation (SMI) device, the Softhaler\u00ae. As invoX\u2019s designated industrialisation and manufacturing partner, H&T Presspart will mould components and produce sub-assemblies in a dedicated clean room at their site in Tarragona, Spain.","og_url":"https:\/\/presspart.com\/es\/invox-pharma-and-ht-presspart-announce-strategic-partnership-to-manufacture-the-device-sub-assembly-for-commercialisation-of-the-softhaler\/","og_site_name":"H&T Presspart","article_published_time":"2024-10-04T08:54:06+00:00","article_modified_time":"2024-11-07T12:05:26+00:00","og_image":[{"url":"https:\/\/presspart.com\/wp-content\/uploads\/2024\/10\/Website-News-Heads-1024x443.png","type":"","width":"","height":""}],"author":"presspart","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"presspart","Tiempo de lectura":"4 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/presspart.com\/es\/invox-pharma-and-ht-presspart-announce-strategic-partnership-to-manufacture-the-device-sub-assembly-for-commercialisation-of-the-softhaler\/#article","isPartOf":{"@id":"https:\/\/presspart.com\/es\/invox-pharma-and-ht-presspart-announce-strategic-partnership-to-manufacture-the-device-sub-assembly-for-commercialisation-of-the-softhaler\/"},"author":{"name":"presspart","@id":"https:\/\/presspart.com\/es\/#\/schema\/person\/ea6faba4b50e03fce829becbe473e66f"},"headline":"invoX Pharma y H&T Presspart anuncian una colaboraci\u00f3n estrat\u00e9gica para fabricar el subconjunto del dispositivo para la comercializaci\u00f3n del Softhaler\u00ae.","datePublished":"2024-10-04T08:54:06+00:00","dateModified":"2024-11-07T12:05:26+00:00","mainEntityOfPage":{"@id":"https:\/\/presspart.com\/es\/invox-pharma-and-ht-presspart-announce-strategic-partnership-to-manufacture-the-device-sub-assembly-for-commercialisation-of-the-softhaler\/"},"wordCount":795,"image":{"@id":"https:\/\/presspart.com\/es\/invox-pharma-and-ht-presspart-announce-strategic-partnership-to-manufacture-the-device-sub-assembly-for-commercialisation-of-the-softhaler\/#primaryimage"},"thumbnailUrl":"https:\/\/presspart.com\/wp-content\/uploads\/2024\/10\/Website-News-Heads-1024x443.png","articleSection":["Noticias de Empresa","Productos y Servicios"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/presspart.com\/es\/invox-pharma-and-ht-presspart-announce-strategic-partnership-to-manufacture-the-device-sub-assembly-for-commercialisation-of-the-softhaler\/","url":"https:\/\/presspart.com\/es\/invox-pharma-and-ht-presspart-announce-strategic-partnership-to-manufacture-the-device-sub-assembly-for-commercialisation-of-the-softhaler\/","name":"invoX Pharma and H&T Presspart Announce Strategic Partnership","isPartOf":{"@id":"https:\/\/presspart.com\/es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/presspart.com\/es\/invox-pharma-and-ht-presspart-announce-strategic-partnership-to-manufacture-the-device-sub-assembly-for-commercialisation-of-the-softhaler\/#primaryimage"},"image":{"@id":"https:\/\/presspart.com\/es\/invox-pharma-and-ht-presspart-announce-strategic-partnership-to-manufacture-the-device-sub-assembly-for-commercialisation-of-the-softhaler\/#primaryimage"},"thumbnailUrl":"https:\/\/presspart.com\/wp-content\/uploads\/2024\/10\/Website-News-Heads-1024x443.png","datePublished":"2024-10-04T08:54:06+00:00","dateModified":"2024-11-07T12:05:26+00:00","author":{"@id":"https:\/\/presspart.com\/es\/#\/schema\/person\/ea6faba4b50e03fce829becbe473e66f"},"description":"H&T Presspart will manufacture the device sub-assembly for the commercialisation of invoX\u2019s complex soft mist inhalation (SMI) device, the Softhaler\u00ae. As invoX\u2019s designated industrialisation and manufacturing partner, H&T Presspart will mould components and produce sub-assemblies in a dedicated clean room at their site in Tarragona, Spain.","breadcrumb":{"@id":"https:\/\/presspart.com\/es\/invox-pharma-and-ht-presspart-announce-strategic-partnership-to-manufacture-the-device-sub-assembly-for-commercialisation-of-the-softhaler\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/presspart.com\/es\/invox-pharma-and-ht-presspart-announce-strategic-partnership-to-manufacture-the-device-sub-assembly-for-commercialisation-of-the-softhaler\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/presspart.com\/es\/invox-pharma-and-ht-presspart-announce-strategic-partnership-to-manufacture-the-device-sub-assembly-for-commercialisation-of-the-softhaler\/#primaryimage","url":"https:\/\/presspart.com\/wp-content\/uploads\/2024\/10\/Website-News-Heads-1024x443.png","contentUrl":"https:\/\/presspart.com\/wp-content\/uploads\/2024\/10\/Website-News-Heads-1024x443.png"},{"@type":"BreadcrumbList","@id":"https:\/\/presspart.com\/es\/invox-pharma-and-ht-presspart-announce-strategic-partnership-to-manufacture-the-device-sub-assembly-for-commercialisation-of-the-softhaler\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/presspart.com\/es\/"},{"@type":"ListItem","position":2,"name":"invoX Pharma y H&T Presspart anuncian una colaboraci\u00f3n estrat\u00e9gica para fabricar el subconjunto del dispositivo para la comercializaci\u00f3n del Softhaler\u00ae."}]},{"@type":"WebSite","@id":"https:\/\/presspart.com\/es\/#website","url":"https:\/\/presspart.com\/es\/","name":"H&T Presspart","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/presspart.com\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Person","@id":"https:\/\/presspart.com\/es\/#\/schema\/person\/ea6faba4b50e03fce829becbe473e66f","name":"presspart","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/presspart.com\/es\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/f132ba1b1a5a3d6f3cb6529cef071eedff6082ffed6f37fb7fbbf8dde5dedb6e?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/f132ba1b1a5a3d6f3cb6529cef071eedff6082ffed6f37fb7fbbf8dde5dedb6e?s=96&d=mm&r=g","caption":"presspart"},"sameAs":["http:\/\/presspart.local"],"url":"https:\/\/presspart.com\/es\/author\/presspart\/"}]}},"_links":{"self":[{"href":"https:\/\/presspart.com\/es\/wp-json\/wp\/v2\/posts\/6003","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/presspart.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/presspart.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/presspart.com\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/presspart.com\/es\/wp-json\/wp\/v2\/comments?post=6003"}],"version-history":[{"count":3,"href":"https:\/\/presspart.com\/es\/wp-json\/wp\/v2\/posts\/6003\/revisions"}],"predecessor-version":[{"id":6015,"href":"https:\/\/presspart.com\/es\/wp-json\/wp\/v2\/posts\/6003\/revisions\/6015"}],"wp:attachment":[{"href":"https:\/\/presspart.com\/es\/wp-json\/wp\/v2\/media?parent=6003"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/presspart.com\/es\/wp-json\/wp\/v2\/categories?post=6003"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/presspart.com\/es\/wp-json\/wp\/v2\/tags?post=6003"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}